Ponte Vedra pharmaceutical company debuts on Nasdaq - Jacksonville Business Journal

📆 20-1-2023 20:16:00
📰 JaxBizJournal

⏱ Reading Time:
20 sec. here
2 min. at publisher
📊 Quality Score:
News: 11%
Publisher: 51%

Nederland Nieuws Nieuws

Nederland Laatste Nieuws,Nederland Headlines

The company is led by the former CEO of one of Jacksonville's fastest-growing companies of the past.

A biopharmaceutical startup led by the former CEO of one Jacksonville's fastest-growing companies debuted on the Nasdaq stock exchange on Friday, priced at $5 a share.

The drug being developed by Cadrenal is an oral anti-coagulant that Pham has previously said could replace warfarin as a standard medication. The company is looking to sell 1.4 million shares of stock, raising $7 million before expenses. Various existing shareholders, including the Boys & Girls Club of Northeast Florida, are expected to sell another 1.7 million shares.

Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder:

Schrijf commentaar

Nederland Laatste Nieuws, Nederland Headlines

Similar News:Je kunt ook nieuwsberichten lezen die vergelijkbaar zijn met deze die we uit andere nieuwsbronnen hebben verzameld.

Jacksonville hospitals ranked among best in U.S. by Healthgrades - Jacksonville Business JournalMayo Clinic and a pair of HCA facilities made the exclusive list. How much did these hospitals pay Healthgrades for their rankings?
Bron: JaxBizJournal - 🏆 599. / 51 Lees verder »

Mark Cuban on disrupting the pharmaceutical industry - CEO SpotlightMark Cuban, CEO of Cuban Companies, joins David Johnson on this episode of CEO Spotlight.
Bron: KRLD - 🏆 75. / 68 Lees verder »

Study: Florida among states with most new home builds - Jacksonville Business JournalUtah is the state with the most new construction homes being developed, with 11.7 new builds per 1,000 residents.
Bron: JaxBizJournal - 🏆 599. / 51 Lees verder »